With the advent of new technologies, big data, precision medicine, artificial intelligence, telemedicine and healthcare, and advanced medical devices are becoming major issues. However, the industrial and the public objectives pursued by technology can be in conflict. The technology itself is value-neutral, but each objective is different, so it is necessary to consider both the industrial and public aspects. In this study, we propose a comprehensive performance improvement plan that maximizes the socio-economic impact not only from economic benefits but also from long - term perspective, so that the virtuous cycle structure such as development of healthcare technology, improvement of national health level. The main objectives of this study are as follows. - Consideration of the domestic and overseas status of future healthcare technology - Present status of investment in healthcare R & D and present policy task - Analysis of R & D effect of health industry - Provide a comprehensive improvement plan of healthcare technology from the mid- to long-term perspective In Chapter 2, we looked at the current status of future healthcare technology at home and abroad. In Chapter 3, we focused on the health and medical technology R & D investments and policy issues to secure future healthcare technology. The current status of R & D investment related to health care, prioritization plans, budget allocation and adjustment plans were examined. In Chapter 4, we analyzed the investment effects through research on the health industry. It creates the economic effects of the health industry, creates value-added effects, and creates induced-employment effects. If the management of R & D investment is carried out more systematically in consideration of the relative size of the impact by the inducement effect by the health industry and the investment of the government. It can contribute to health promotion.  

Abstract ················································································································1

Ch 1. Introduction ·························································································5

  A. Research Background and Purpose ··················································································7

  B. Research Contents and Methods ················································································18

Ch 2. Current State of Domestic and Foreign Future Healthcare Technology ·······································19

  A. The Examples of Future Healthcare Technology ·····································································21

  B. Government Support for Healthcare Technologies in Selected Countries ················································26

  C. The Effects of Future Healthcare Technology ···························································35

  D. Current State of Korea's Future Healthcare Technology ·····················································41

Ch 3. Korea's Healthcare R&D Investment: Current State and Policy Implications ····························59

  A. Current State of the Government's Healthcare R&D Investment ····························································61

  B. Healthcare R&D Governance ····································································70

Ch 4. Analysis of the Health Industry R&D's Ripple Effects ···········································77

  A. Health Industry Structure Analysis ·················································································79

  B. The Economic Effects of the Health Industry ··········································································86

  C. The Effects of the R&D Investment of the Health Industry ····························································91

  D. Developing a Dynamic Analysis Model for Health Industry R&D Investment ··········································96

  E. Chapter Conclusion ·····································································································102

Ch 5. Conclusion ·····················································································105

References ···························································································125